{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:26:50Z","timestamp":1788690410486,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1053\/j.semdp.2011.03.001","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T09:20:35Z","timestamp":1308561635000},"page":"135-145","source":"Crossref","is-referenced-by-count":15,"title":["Marginal zone lymphoma"],"prefix":"10.1053","volume":"28","author":[{"given":"Miguel A.","family":"Piris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2011.03.001_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","article-title":"Human marginal zone B cells","volume":"27","author":"Weill","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.semdp.2011.03.001_bib2","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-03-0750","article-title":"Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT)","volume":"102","author":"Falini","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib3","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma: A distinctive type of low-grade B-cell lymphoma","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","article-title":"The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders","volume":"83","author":"Matutes","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib7","first-page":"148","article-title":"Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib8","first-page":"294","article-title":"Splenic B cell lymphoma with \u201cvillous\u201d lymphocytes in the peripheral blood: A disorder distinct from hairy cell leukemia","volume":"1","author":"Melo","year":"1987","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: Clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chac\u00f3n","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients","volume":"93","author":"Troussard","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib12","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.03.001_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0035-9203(97)90211-X","article-title":"Circulating villous lymphocytes\u2014A link between hyperreactive malarial splenomegaly and splenic lymphoma","volume":"91","author":"Bates","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1053\/j.semdp.2011.03.001_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2005.04.009","article-title":"Marginal zone B cells in lymphocyte activation and regulation","volume":"17","author":"Lopes-Carvalho","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.semdp.2011.03.001_bib17","first-page":"1015","article-title":"Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: A helpful immunohistologic feature","volume":"10","author":"Labouyrie","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","article-title":"Intrasinusoidal bone marrow infiltration: A possible hallmark of splenic lymphoma","volume":"29","author":"Franco","year":"1996","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.03.001_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199707000-00005","article-title":"Lymph node involvement by splenic marginal zone lymphoma: Morphological and immunohistochemical features","volume":"21","author":"Mollejo","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib20","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","article-title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","volume":"97","author":"Gruszka-Westwood","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3324\/haematol.2009.011049","article-title":"CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: A clinico-pathological, cytogenetic and molecular study of 24 cases","volume":"95","author":"Baseggio","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.03.001_bib22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: A multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2141.1997.2163033.x","article-title":"Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma","volume":"98","author":"Sole","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0165-4608(96)00025-8","article-title":"Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders","volume":"92","author":"Oscier","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.semdp.2011.03.001_bib26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib27","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: Two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sol\u00e9","year":"2001","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.03.001_bib28","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/sj.onc.1203033","article-title":"Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations","volume":"18","author":"Corcoran","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2011.03.001_bib29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: A description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.leu.2402073","article-title":"Molecular heterogeneity of splenic marginal zone lymphomas: Analysis of mutations in the 5\u2032 non-coding region of the bcl-6 gene","volume":"15","author":"Mateo","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","article-title":"Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course","volume":"99","author":"Algara","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2010.08347.x","article-title":"Immunogenetics features and genomic lesions in splenic marginal zone lymphoma","volume":"151","author":"Rinaldi","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib34","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib35","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","article-title":"MicroRNA losses in the frequently deleted region of 7q in SMZL","volume":"21","author":"Ruiz-Ballesteros","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2008.07176.x","article-title":"Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes","volume":"142","author":"Vega","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","article-title":"Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes","volume":"40","author":"Lefr\u00e8re","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.03.001_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.seminhematol.2010.01.004","article-title":"Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab","volume":"47","author":"Bennett","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","article-title":"Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes","volume":"14","author":"Lefr\u00e8re","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib40","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: A distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: A diffuse variant of splenic marginal zone lymphoma?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.03.001_bib42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: Revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2011.03.001_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0145-2126(80)90066-1","article-title":"A chronic lymphoproliferative disorder with distinctive features: A distinct variant of hairy-cell leukaemia","volume":"4","author":"Cawley","year":"1980","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.03.001_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","article-title":"The natural history and clinico-pathological features of the variant form of hairy cell leukemia","volume":"15","author":"Matutes","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib45","series-title":"et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.semdp.2011.03.001_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<242::AID-AJH8>3.0.CO;2-A","article-title":"Splenic involvement by blastic mantle cell lymphoma (large cell\/anaplastic variant) mimicking splenic marginal zone lymphoma","volume":"62","author":"Mollejo","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib47","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2559.1998.00478.x","article-title":"A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: The morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma","volume":"33","author":"Piris","year":"1998","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.03.001_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2559.1996.tb01392.x","article-title":"Monocytoid\/marginal zone B-cell differentiation in follicle centre cell lymphoma","volume":"29","author":"Schmid","year":"1996","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.03.001_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","article-title":"Splenic marginal zone lymphoma with or without plasmacytic differentiation","volume":"24","author":"Van Huyen","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib51","first-page":"310","article-title":"Monocytoid B-cell lymphoma","volume":"124","author":"Sheibani","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ajcp\/87.1.121","article-title":"Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called \u201cmonocytoid\u201d lymphocytes","volume":"87","author":"Cousar","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2559.1988.tb01953.x","article-title":"Monocytoid B-cell lymphoma, a tumour related to the marginal zone","volume":"12","author":"Piris","year":"1988","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.03.001_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0609.2009.01301.x","article-title":"Nodal marginal zone lymphoma: Current knowledge and future directions of an heterogeneous disease","volume":"83","author":"Arcaini","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2011.03.001_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000478-199901000-00006","article-title":"Primary nodal marginal zone lymphomas of splenic and MALT type","volume":"23","author":"Campo","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib56","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: A heterogeneous tumor: A comprehensive analysis of a series of 27 cases","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib57","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)64087-4","article-title":"Unique phenotypic profile of monocytoid B cells: Differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma","volume":"158","author":"Camacho","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000478-200304000-00014","article-title":"Marginal zone B-cell lymphoma in children and young adults","volume":"27","author":"Taddesse-Heath","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdl388","article-title":"Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT","volume":"18","author":"Arcaini","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2011.03.001_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.03.001_bib61","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: From morphology to molecules","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2011.03.001_bib62","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"L\u00e9vy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.03.001_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/leu.2009.234","article-title":"A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma","volume":"24","author":"Chanudet","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.03.001_bib64","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.03.001_bib65","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-kappaB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T12:20:22Z","timestamp":1592655622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257011000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0740257011000207"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2011.03.001","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}